Biography/Memoir

…[The Oregonian newspaper editorial board] vote ‘no’ on Measure 109’s ill-timed psilocybin proposal

This shouldn’t be a priority for the Oregon Health Authority, particularly amid a pandemic with no clear end in sight… …the measure [estimated to cost over 6 million dollars during the next two years], if passed, would give the Oregon Health Authority two years to work with [a self-appointed] advisory board in developing the regulatory…

READ MORE
Biography/Memoir

No on Measure 109…

I cannot support Measure 109 for the following reasons… there are two different ballot measures this fall that would change state law (and only state law) regarding the possession and use of psilocin – the active ingredient in “magic” psilocybin mushrooms. The proponents of Measure 109 are focused on setting up specialty facilities and services…

READ MORE
Biography/Memoir

Psilocybin Measure 109: pros and cons

We talked to a supporter and opponent… [Nichole, an opponent], “We do not feel it is safe to be giving Oregonians psilocybin…” and also states that the science is not ready to support psilocybin use for mental health conditions as Measure 109 claims… other local and national organizations also oppose the measure. [Thomas, a supporter]:…

READ MORE
Biography/Memoir

The first psychedelic patent troll?

 The term “patent troll” best describes… [those seeking] to extract royalties from other practicing entities by leveraging its patent portfolio [in Cahoots with the Controlled Substances Act of 1970]. On the one hand, [for-profit psychedelic actors are] candid about their lack of interest in clinically developing their compounds in favor of “partnering” with others interested in…

READ MORE
Biography/Memoir

We need to talk about [the psychedelic investor class] supporting the police, the military, and violent white supremacism

…[a] willingness to accept funding from all-things-conservative financier Rebekah Mercer and ATAI Life Sciences’ founder Christian Angermayer, and its unwillingness to speak out against Peter Thiel, the chairman of Palantir and recent investor in defense-contractor startup Anduril. As long as its strategy relies on supporting the police and the military (institutions that exist to perpetuate white supremacism, class warfare, and imperialism) it’s…

READ MORE
Biography/Memoir

…[potentially reverse engineerable synthetic psilocybin “mushrooms” patent] made one investor $316 million

“A very special tattoo – actually my first one ever – for a very special day…” -[said Christian Angermayer]… “Palantir is going public, meaning they will be able to make money on Wall Street while working [with] ICE,” MSC wrote in a tweet. Many of the outside backers that Angermayer brought into Compass are also…

READ MORE
Biography/Memoir

Compass Pathways… a psychedelic monopoly

COMPASS patent… compared to proprietary insulin formulations and asthma inhalers created to increase corporate profits… will share similar issues to “big pharma, big tech, big ag [agriculture], and other monopoly-heavy industries.” COMPASS’s attempt to dismiss the dispute against their patent… “Although Patent Owner does not address the substance of Petitioner’s challenge, after considering the arguments…

READ MORE
Biography/Memoir

…[Synthetic psilocybin] drug-backer Compass Pathways files for U.S. IPO

The London-based firm filed to raise US$100 million, a placeholder amount likely to change, according to a filing Friday [8/28/2020] with the U.S. Securities and Exchange Commission. …has seen a renaissance in recent years in the scientific community. Scientists can’t exactly explain why psychedelics appear to help patients. Emerging brain-scanning technology suggests the substances can…

READ MORE